Maryland 2026 Session Status: Introduced 1 D cosponsors

HB1045 — Prescription Drug Monitoring Program - Data Disclosure to Federal Law Enforcement - Limitation

Last action — Committee Report (House of Origin) — Withdrawn

  1. 1
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House of Delegates
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill has been introduced in the House of Delegates. Introduced February 09, 2026. It must pass committee before a floor vote.

Next likely step: a committee referral and hearing.

Odds of enactment

Low chance

Based on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Not enough signal yet

Not enough signal yet to read this bill's trajectory — we surface a likelihood only once there's real movement (stage, sponsorship, committee, or votes) to point to.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Summary

Altering the circumstances under which the Prescription Drug Monitoring Program is required to disclose prescription monitoring data to a federal law enforcement agency to prohibit the disclosure if the Protected Health Care Commission determines that the data is sensitive health services information that has been determined by the Secretary of Health to be legally protected health care.

Bill Text

We don't have the full text on file for this bill yet.

Read HB1045 on the official Maryland source →

Action History

  1. Committee Report (House of Origin) — Withdrawn

  2. First Reading (House of Origin)

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 187 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (187)

187 members have not signed on to this bill.

Show all 187 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

public-safety healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB1045 do?
Altering the circumstances under which the Prescription Drug Monitoring Program is required to disclose prescription monitoring data to a federal law enforcement agency to prohibit the disclosure if the Protected Health Care Commission determines that the data is sensitive health services information that has been determined by the Secretary of Health to be legally protected health care.
Who sponsors HB1045?
HB1045 is sponsored by Delegate Bonnie Cullison (Democrat).
What is the current status of HB1045?
This bill has been introduced in the House of Delegates. Introduced February 09, 2026. It must pass committee before a floor vote.
Where can I track HB1045?
Track HB1045 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB1045

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB1045

Last checked for changes 14 minutes ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →